CGON
CG Oncology, Inc.
77.70$
-0.7%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.5% | 99.6% | 97.4% | 99.9% | 95.9% | |
| 91.3% | 59.7% | 4.1% | 34.1% | 4.1% | |
| 91.3% | 97.1% | 94.2% | 98.3% | 93.8% | |
| 0.0% | 0.2% | 0.0% | 0.1% | 0.1% | |
| – | – | – | 0.0% | 0.2% | |
| – | – | – | 0.0% | 1.3% | |
| – | – | – | – | 0.1% | |
| 31.4% | 15.3% | 7.3% | 2.8% | 4.9% | |
| 10.2% | 10.4% | 7.2% | 2.8% | 3.9% | |
| 5.1% | 6.2% | 0.4% | 0.0% | 0.1% | |
| 1.7% | 0.7% | 1.6% | 0.9% | 0.7% | |
| 20.6% | 4.4% | – | – | 0.4% | |
| 68.6% | 84.7% | 92.7% | 97.2% | 95.1% | |
| -78.2% | -55.1% | -65.2% | -28.9% | -47.9% | |
| 113.5% | 45.1% | 33.4% | 8.3% | 9.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.